Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
City of Hope Medical Center
Jonsson Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sarcoma Alliance for Research through Collaboration
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Dana-Farber Cancer Institute
NYU Langone Health
City of Hope Medical Center
City of Hope Medical Center
Dartmouth-Hitchcock Medical Center
Memorial Sloan Kettering Cancer Center
Duke University
University of Kentucky
Memorial Sloan Kettering Cancer Center
OHSU Knight Cancer Institute
Swiss Cancer Institute
Sarcoma Alliance for Research through Collaboration
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center